APOC3 variants can impair triglyceride clearance, raising risk for hypertriglyceridemia, pancreatitis, and cardiovascular disease. Here’s how to interpret your CardiaX result and mitigate the risks.
The CYP4F2 gene polymorphism (rs2108622, V433M) alters vitamin K metabolism and blood pressure regulation, raising the risk of hypertension and cardiovascular disease. Here’s how to...
The CYP11B2 −344C/T polymorphism influences aldosterone synthesis, making carriers more prone to hypertension, left ventricular hypertrophy, and cardiovascular complications. Here’s what your CardiaX result means...
The 1q25 locus (rs10911021) sits near GLUL, the gene for glutamine synthetase. In people with type 2 diabetes, this variant associates with higher...
The 4q25 variant on CardiaX testing links to atrial fibrillation risk. Here’s how it works, what raises its impact, and evidence-based strategies to...
CTACK (Cutaneous T-cell Attracting Chemokine) is a key inflammatory marker measured on the SmartVascularDx PULS test. Elevated CTACK levels signal increased cardiovascular disease risk. Discover...
